Q2 2022 Earnings Estimate for FibroGen, Inc. Issued By William Blair (NASDAQ:FGEN)
FibroGen, Inc. (NASDAQ:FGEN – Get Rating) – Equities researchers at William Blair lowered their Q2 2022 earnings estimates for FibroGen in a report issued on Tuesday, May 10th. William Blair analyst A. Hsieh now forecasts that the biopharmaceutical company will post earnings per share of ($0.77) for the quarter, down from their prior forecast of […]